Daegu
South Korea
26
2026-03-26
The entities that hold a legal rights for patent applications filed by inventor Lee Byung-Heon:
Byung-Heon Lee from Daegu, KR has applied for patents for these inventions. The list has both pending applications and granted patents:
PEPTIDES THAT SELECTIVELY BIND TO Trop2 AND USE THEREOF
#2 | 2025-05-15PEPTIDE BINDING TO MESOTHELIN, AND USE THEREOF
#3 | 2024-06-20USE OF ODORANT RECEPTOR FOR SUPPRESSING LACTATE-INDUCED M2-TYPE DIFFERENTIATION OF TUMOR-ASSOCIATED MACROPHAGES AND TUMOR GROWTH
#4 | 2023-11-23FERRITIN NANOCAGE FUSED WITH PD-L1-BINDING PEPTIDE 1 AND USE THEREOF AS ANTICANCER IMMUNOTHERAPY AGENT
#5 | 2023-09-21PEPTIDE SELECTIVELY BINDING TO CANCER CELL-DERIVED EXOSOME, AND USES THEREOF
#6 | 2022-06-09FERRITIN NANOCAGE FOR MULTI-DISPLAYING TRAIL TRIMER AND CANCER-TARGETING PEPTIDE AND USE THEREOF AS ANTICANCER AGENT
#7 | 2021-06-03Peptides for binding to CD44v6 and use thereof
#8 | 2021-06-03Peptide bound to PD-L1 and use thereof
#9 | 2018-07-19PHARMACEUTICAL COMPOSITION THAT IS ANTICANCER AND SUPPRESSES CANCER METASTASIS, CONTAINING, AS ACTIVE INGREDIENT, FUSION PEPTIDE SIMULTANEOUSLY TARGETING CANCER CELL AND TUMOR ASSOCIATED MACROPHAGE
#10 | 2018-06-07Cancer cell-targeting peptide and use thereof
#11 | 2018-01-04Peptide for targeting autophagic cells and use thereof
#12 | 2017-11-30CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF
#13 | 2015-02-19Drug Delivery Conjugate Capable of Controlled Release, and Use Thereof
#14 | 2014-03-20Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
#15 | 2012-12-13Peptides for targeting apoptotic cells and uses thereof
#16 | 2012-11-22Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
#17 | 2012-11-15Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
#18 | 2012-10-11USES OF APOPTOTIC CELL-TARGETING PEPTIDES, LABEL SUBSTANCES AND LIPOSOMES CONTAINING A THERAPEUTIC AGENT FOR PREVENTING, TREATING OR THERAPEUTICALLY DIAGNOSING APOPTOSIS-RELATED DISEASES
#19 | 2011-06-23Stroke-targeting peptide and use thereof
#20 | 2009-11-19Peptides for targeting apoptotic cells and uses thereof
#21 | 2009-08-27Polypeptide specifically bound to phosphatidylserine and the use thereof
#22 | 2009-03-19Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
#23 | 2008-11-06Novel Use of a Polypeptide Comprising Fas-1 Domain
#24 | 2008-06-12Bladder tumor-targeting peptide and use thereof
#25 | 2007-07-19Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motif
#26 | 2007-01-04Use of a peptide that interacts with Ī±vĪ²3 integrin of endothelial cell
694207 ā